George Karavetsos, shareholder in the firm’s FDA & Biotechnology and White Collar, Compliance & Investigations practices, was quoted in The Philadelphia Inquirer article, “These kids signed up to test a COVID-19 vaccine, but it will be months before approval.” George provides insight on what FDA regulators will be looking at when it comes to authorizing COVID-19 vaccines for emergency use in children.
We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.
Already a subscriber and want to update your preferences? Click here.